证券代码：600266 证券简称：城建发展 公告编号：2025-28 北京城建投资发展股份有限公司 | 1、出席会议的股东和代理人人数 | 411 | | --- | --- | | 2、出席会议的股东所持有表决权的股份总数（股） | 1,163,065,209 | | 3、出席会议的股东所持有表决权股份数占公司有表决权股 | | | 份总数的比例（%） | 56.0312 | (四)表决方式是否符合《公司法》及《公司章程》的规定，大会主持情况等。 2024年年度股东大会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 本次会议是否有否决议案：无 一、 会议召开和出席情况 (一)股东大会召开的时间：2025 年 6 月 26 日 (二)股东大会召开的地点：北京市朝阳区北土城西路 11 号城建开发大厦九楼会 议室 (三)出席会议的普通股股东和恢复表决权的优先股股东及其持有股份情况： 本次会议由公司董事会召集，采取现场和网络投票相结合的方式召开，公司董事 长储昭武先生主持了会议。现场会议采取记名投票表决的方 ...

金杜律师事务所 KING&WODD MALLESONS 北京市朝阳区东三环中路1号 不球金融中心办公室东楼18 18th Floor, East Tower, World Fin 1 Donosanhuan Zhonole Chaovang Distric Relina, 100020 北京市金社律师事务所 关于北京城建投资发展股份有限公司 2024 年年度股东大会 之法律意见书 致:北京城建投资发展股份有限公司 北京市金杜律师事务所（以下简称本所）接受北京城建投资发展股份有限公 司(以下简称公司)委托,根据《中华人民共和国证券法》(以下简称《证券法》)、 《中华人民共和国公司法》(以下简称《公司法》)、中国证券监督管理委员会《上 市公司股东会规则(2025 修订)》(以下简称《股东会规则》》等中华人民共和国 境内(以下简称中国境内,为本法律意见书之目的,不包括中国香港特别行政区、 中国澳门特别行政区和中国台湾省）现行有效的法律、行政法规、规章和规范性 文件和现行有效的公司章程有关规定,指派律师出席了公司于 2025年6月26日 召开的 2024 年年度股东大会（以下简称本次股东大会）,并就本次股东大会相关 ...

第九届董事会第十九次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 2025 年 6 月 26 日，北京城建投资发展股份有限公司（以下简称 "公司"）第九届董事会第十九次会议在公司九楼会议室召开，会议 通知和材料已于 2025 年 6 月 23 日通过书面及电子通讯方式送达全体 董事。本次会议应参会董事 7 人，实际参会董事 6 人，独立董事宋建 波因公务原因未能亲自出席会议，委托独立董事张成思代为出席并表 决。董事长储昭武主持了会议，公司部分高级管理人员列席了会议。 本次会议的召开符合《公司法》等有关法律、法规和《公司章程》规 定。 二、董事会会议审议情况 本次会议审议通过了关于兴胜公司向民生银行申请不超过 5.35 亿元贷款并由公司为其提供担保的议案。 公司原持有北京城建兴胜置业有限公司（以下简称"兴胜公司"） 90%股权，2025 年 5 月 16 日，公司召开第九届董事会第十五次会议， 证券代码：600266 证券简称：城建发展 公告编号：2025-29 北京城建投资发展股份有限公 ...

证券代码：600266 证券简称：城建发展 公告编号：2025－27 北京城建投资发展股份有限公司 关于收购北京城建兴胜置业有限公司 10%股权及债务处理进展 情况的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 司"）第九届董事会第十五次会议在公司六楼会议室召开，审议通过 了《关于收购北京城建兴胜置业有限公司10%股权及债务处理的议 案》，同意公司根据审计、评估结果，收购北京怀胜城市建设开发有 限公司（以下简称"怀胜公司"）持有的北京城建兴胜置业有限公司 （以下简称"兴胜公司"）10%股权，并由兴胜公司清偿所欠怀胜公 司的债务。 挂牌转让所持兴胜公司 10%股权。 经 审 计 、 评 估 ， 截 止 2024 年 6 月 30 日 ， 兴 胜 公 司 净 资 产 司所持兴胜公司 10%股权的价格为 12,844,178.75 元。同时，兴胜公 司需向怀胜公司清偿债务本息为 113,164,142.49 元，由兴胜公司支付 现金对价 35,900,979.49 元，以府前龙樾项目共计 16 套商品房原价的 胜公司支 ...

Core Viewpoint - Beijing Urban Construction Investment Development Co., Ltd. (referred to as "Urban Development") is undergoing management changes to revitalize its real estate business amid ongoing market adjustments and past performance fluctuations [2][3][10]. Group 1: Management Changes - Zou Zhe has been appointed as the new Party Secretary of Urban Development, replacing Shu Zhaowu, who will no longer hold this position [2][3]. - Shu Zhaowu has served in various roles within the company since 2012, including Vice General Manager and Party Secretary, and will continue as Chairman until July 2027 [5][8]. - The management change is seen as part of Beijing Urban Construction Group's strategy to enhance its real estate operations during a challenging market period [3][10]. Group 2: Financial Performance - Urban Development has experienced significant fluctuations in performance, with net profit dropping to 640 million yuan in 2021 and incurring losses of 926 million yuan in 2022 and 951 million yuan in 2023 [5][6]. - Despite achieving a record revenue of 25.44 billion yuan in 2023, the company still reported losses due to declining gross margins and increased asset impairment losses [6][7]. - The gross margin for real estate development fell to 14.1%, a decrease of 4.2 percentage points year-on-year, with a more significant drop in the Beijing region [7]. Group 3: Strategic Focus - Urban Development's management emphasizes the importance of cash flow management, particularly in light of the company's recent performance challenges [11]. - The company aims to enhance its real estate development efforts by focusing on both new land acquisitions and the liquidation of existing projects to ensure financial stability [11]. - In the first quarter of the current year, Urban Development reported a significant revenue increase of 435.9% year-on-year, achieving total revenue of 6.614 billion yuan and a net profit of 43.17 million yuan [12].

日前，公司取得北交所出具的《受让资格确认通知书》，成为兴 胜公司10%股权的合格意向受让方，并一次性支付转让价款 1,284.417875万元，取得北交所出具的《企业国有资产交易凭证》， 股权收购完成后，兴胜公司成为公司全资子公司。 关于收购北京城建兴胜置业有限公司 10%股权及债务处理进展 情况的公告 特此公告。 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 2025年5月16日，北京城建投资发展股份有限公司（以下简称"公 司"）第九届董事会第十五次会议在公司六楼会议室召开，审议通过 了《关于收购北京城建兴胜置业有限公司10%股权及债务处理的议 案》，同意公司根据审计、评估结果，收购北京怀胜城市建设开发有 限公司（以下简称"怀胜公司"）持有的北京城建兴胜置业有限公司 （以下简称"兴胜公司"）10%股权，并由兴胜公司清偿所欠怀胜公 司的债务。 兴胜公司成立于 2019 年 7 月 5 日，注册资本 10000 万元（已全 部实缴），公司持股 90%，怀胜公司持股 10%，负责开发建设怀柔区 府前龙樾项目。怀胜公司通过北 ...

Group 1 - Chengjian Development received a dividend of 7.1282 million yuan from Beijing Jingcheng Jiaye Property Co., Ltd., in which it holds a 33.47% stake [1] - Shengnuo Bio expects a net profit attributable to shareholders of 77.0275 million to 94.1448 million yuan for the first half of 2025, representing a year-on-year increase of 253.54% to 332.10% [1] - JKN2301 dry mixed suspension has been approved for clinical trials, targeting children with influenza [5][6] Group 2 - Jindawei obtained a patent for a method of purifying natto kinase, with a validity of twenty years [2] - CITIC Guoan plans to increase its stake in China Broadcasting Hunan Company to approximately 5.29% through a capital increase of 278 million yuan [2] - Ji Electric announced the resignation of its general manager, Niu Guojun, due to work changes [3] Group 3 - Xintian Green Energy successfully issued 1.5 billion yuan in green medium-term notes with a term of 3+N years and an interest rate of 2.05% [7] - Hengrun Co. plans to invest 1.2 billion yuan in a project to produce 2,000 sets of wind turbine gearbox components [9] - Pulaide received a government subsidy of 10 million yuan, accounting for 15.87% of its audited net profit for the last fiscal year [10] Group 4 - Boteng Co. passed the EU QP audit, receiving a compliance statement for its CDMO services [12] - Zhou Dasheng added 7 self-operated stores in May, with total investments ranging from 900,000 to 6.5 million yuan [13] - Wantai Bio initiated a Phase III clinical trial for its live attenuated varicella vaccine [15] Group 5 - Shanghai Pharmaceuticals received a drug registration certificate for Pregabalin capsules in Thailand [19] - Sanxing Medical's subsidiary is expected to win contracts worth approximately 143 million yuan from State Grid projects [21] - Jiangsu Huachen plans to issue 460 million yuan in convertible bonds [24] Group 6 - Jian Gong Repair won a soil pollution remediation project worth 32.76 million yuan [25] - Dize Pharmaceutical completed patient enrollment for a global Phase III clinical trial of its drug [26] - Del Co. received acceptance for its application to issue shares for asset acquisition and raise matching funds [27] Group 7 - Beijing Kerui won multiple power grid projects with a total value of approximately 154 million yuan [27] - Xie Chuang Data signed financing lease contracts totaling 498 million yuan with Su Yin Financial Leasing [28] - Meige Intelligent submitted an application for H-share listing on the Hong Kong Stock Exchange [29][31] Group 8 - Aikodi plans to repurchase shares worth 100 million to 200 million yuan for employee stock ownership plans [54] - Kong Kong Industrial intends to sell 80% of Tianyuan Construction to its controlling shareholder [55] - Youyou Green Energy proposed a cash dividend of 12 yuan per 10 shares, totaling 50.4 million yuan [55]

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 证券代码：600266 证券简称：城建发展 公告编号：2025－26 北京城建投资发展股份有限公司 关于收到北京京城佳业物业股份有限公司现金分红的公告 北京京城佳业物业股份有限公司（以下简称"京城佳业"）总股 本 14,666.72 万股，北京城建投资发展股份有限公司（以下简称"公 司"）持有 49,092,189 股，占其总股本的 33.47%。公司对京城佳业的 长期股权投资收益按权益法核算。 日前，公司收到京城佳业 2024 年度分红款 7,128,185.84 元。 特此公告。 北京城建投资发展股份有限公司董事会 2025 年 6 月 20 日 ...

Group 1 - Company Xi Zhong Technology proposed to repurchase shares worth between 75 million and 150 million yuan using excess funds and self-owned funds [1] - Company Yongxi Electronics expects a revenue growth of 16.6% to 28.88% in the first half of the year, with projected revenue between 1.9 billion and 2.1 billion yuan [2] - Company Jingyi Equipment anticipates a revenue increase of 36.54% to 42.48%, with expected revenue between 690 million and 720 million yuan [2][3] Group 2 - Company Haipuri received approval from the European Medicines Agency (EMA) for a new production line for Enoxaparin Sodium injection, with an annual capacity of 330 million doses [4] - Company Inner Mongolia Xinhua plans to merge its wholly-owned subsidiaries to optimize resource allocation and improve operational efficiency [5] - Company Cloud Chemical intends to sign daily related transaction framework agreements with its controlling shareholder to reduce operational costs [7] Group 3 - Company China Software received approval from the China Securities Regulatory Commission for a specific stock issuance [8] - Company Wankong Intelligent's subsidiary won a bid for a project with the State Grid worth approximately 12.17 million yuan [9] - Company Lianlong obtained a patent for an anti-aging agent, which is expected to enhance its product offerings in polymer materials [11] Group 4 - Company Yunlu plans to increase its shares by 4 million to 12 million yuan through stock purchases by its executives [12] - Company Enhua Pharmaceutical's chairman increased his stake by 237,900 shares [14] - Company Daqin Railway announced the resignation of its general manager due to retirement [15] Group 5 - Company Hefei Urban Construction signed a land use rights transfer contract for an industrial site with an area of 78,561.78 square meters, with a payment of 103 million yuan due by July 13, 2025 [16] - Company Taiji Group received a government subsidy of 20 million yuan, representing 75.04% of its projected net profit for 2024 [17] - Company Guodian Nanrui elected a new chairman, Zheng Zongqiang, while he resigned from his previous roles [19] Group 6 - Company Xinhua Medical received a medical device registration certificate for a thromboelastography testing kit [20] - Company Baotailong's subsidiary obtained a mining license for a graphite mine with a production capacity of 2 million tons per year [21] - Company Zejing Pharmaceutical received approval for clinical trials of its innovative cancer treatment drugs [22] Group 7 - Company Aojing Medical's artificial bone repair material received registration approval in Vietnam [23] - Company Chengjian Development received a cash dividend of 90.2169 million yuan from Guoxin Securities [24] - Company Rili Technology proposed a share repurchase plan worth between 10 million and 20 million yuan [25] Group 8 - Company Deshi General Institute received approval to issue up to 1 billion yuan in technology innovation bonds [44] - Company Tongding Interconnect plans to bid for two procurement projects worth approximately 717 million yuan [46] - Company Bangji Technology plans to acquire multiple agricultural companies [46]

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 北京城建投资发展股份有限公司（以下简称"公司"）现持有国 信证券股份有限公司25,776.26万股，占其总股本（96.12亿股）的 2.68%。根据国信证券股份有限公司2024年度利润分配方案，公司收 到2024年度分红款9,021.69万元，该笔款项将计入公司2025年度投资 收益。 特此公告。 北京城建投资发展股份有限公司董事会 2025 年 6 月 18 日 证券代码：600266 证券简称：城建发展 公告编号：2025－25 北京城建投资发展股份有限公司 关于收到国信证券股份有限公司现金分红的公告 ...